We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Parse Biosciences Launches Evercode Whole Blood Fixation

Laboratory technician handling labeled blood samples for single cell sequencing analysis.
Credit: iStock.
Read time: Less than a minute

Parse Biosciences announced the launch of EvercodeTM Whole Blood Fixation, a new kit that enables immediate fixation of whole blood directly at the point of collection. The technology eliminates the need for on-site PBMC isolation, specialized equipment, or trained personnel, allowing translational hematology and pharmaceutical research teams to seamlessly collect blood samples in real-world clinical settings for downstream single cell analysis.

 

Traditional single cell RNA profiling workflows done in a translational setting require a compromise between processing fresh samples, which degrade rapidly and demand skilled handling, and using fixation approaches that capture only a partial transcriptome and cannot provide paired TCR sequences. Fresh PBMC isolation also requires complex workflows and specialized reagents. Evercode Whole Blood Fixation overcomes these limitations, preserving the comprehensive, unbiased transcriptome coverage that defines the Evercode platform. The result is a practical, scalable solution for high-quality single cell RNA-seq in translational settings.

 

“We’re excited about what this technology enables for researchers in hematology, biomarker discovery, and translational medicine,” said Charlie Roco, PhD, Chief Technology Officer and Co-founder of Parse Biosciences. “Evercode Whole Blood Fixation brings the power of single cell sequencing directly to blood-based research by stabilizing samples at collection and preserving high-quality transcriptomes for rigorous downstream analysis.”

 

The new Whole Blood Fixation kits are available for shipping starting the week of December 8. 

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.